The deal range was $14.50-$15.00. William Blair acted as lead book running manager for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VKTX:
- Viking Therapeutics Spot Secondary; price range $14.50-$15.00
- Viking Therapeutics announces common stock offering, no amount given
- Viking Therapeutics price target raised to $32 from $28 at Truist
- Viking Therapeutics price target raised to $19 from $15 at Roth MKM
- Viking Therapeutics price target raised to $25 from $15 at Maxim